Diagnosis of Depressive Disorder Malinger Using the Niacin Skin Response Test (NSRT)
Conditions: Depressive Disorder; Malingering Interventions: Diagnostic Test: Niacin skin reaction test Sponsors: Air Force Military Medical University, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials
Evaluation of Safety and Pharmacokinetics of Oral Controlled-ileal-release Nicotinic Acid (CIR-NA) Compared to Immediate-release Nicotinic Acid and Placebo in Healthy Subjects and Subjects With Prediabetes
Conditions: Safety Issues; Pharmacokinetic Interventions: Drug: controlled-ileal-release nicotinic acid (SAD/ MAD/MD) single- and multiple-ascending dose (SAD/MAD) or multiple dose (MD); Drug: immediate-release nicotinic acid (SAD); Drug: Placebo controlled-ileal-release nicotinic acid (SAD/MAD); Drug: Placebo immediate-release nicotinic acid (SAD) Sponsors: University Hospital Schleswig-Holstein Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
Conditions: Depression, Anxiety; Psilocybin-Assisted Psychotherapy; Advanced Cancer Interventions: Drug: Psilocybin; Other: Niacin Sponsors: M.D. Anderson Cancer Center; Gateway for Cancer Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
Conditions: Depression, Anxiety; Psilocybin-Assisted Psychotherapy; Advanced Cancer Interventions: Drug: Psilocybin; Other: Niacin Sponsors: M.D. Anderson Cancer Center; Gateway for Cancer Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
A Study of Niacin Regulation
Conditions: Excessive Weight Gain Interventions: Drug: Niacin Sponsors: Mayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials
A Randomized Neuroimaging Trial of Psilocybin in Depression
Conditions: Depressive Disorder; Major Depressive Disorder Interventions: Drug: Psilocybin; Drug: Niacin Sponsors: Sunnybrook Health Sciences Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2023 Category: Research Source Type: clinical trials
Effect of Nicotinic Acid as Add on Therapy in Patients Receiving β Blocker for Prophylaxis of Moderate to Severe Migraine
Condition: Migraine Prophylaxis Interventions: Drug: Nicotinic Acid 500 MG Extended Release Oral Tablet; Drug: Nicotinic Acid 1000 MG Extended Release Oral Tablet; Other: Placebo Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials
